MIAMI, Sept. 25, 2019 /PRNewswire-PRWeb/ -- DS Healthcare Group Inc. (dslaboratories.com), a leader in the development
Revita.CBD is the newest addition to the renowned Revita line, leading over-the-counter hair-growth products for men and women and recommended and used by dermatologists worldwide.
Revita.CBD, which incorporates cannabidiol, a compound extracted from cannabis, strengthens and thickens hair and improves its appearance. The latest clinical research shows CBD controls inflammation, which is associated with hair-loss conditions such as alopecia, and stimulates hair growth, prevents hair damage and conditions hair. Revita.CBD contains 150 mg of broad-spectrum CBD, which bolsters hair growth in several essential ways:
"The DS Laboratories hair growth technology is designed to work from the root outward, enhancing the volume and density of hair at the source," says Dr. Fernando Tamez, CEO of DS Laboratories and its parent company, DS Healthcare Group.
Revita.CBD is ideal for men and women concerned about hair loss, who are experiencing thinning hair or who have been diagnosed with male or female pattern baldness. The shampoo is also ideal for hair transplant patients.
Purchase seven-ounce bottles of Revita.CBD online at DSLaboratories.com/collections/all/products/revita-cbd-purifying-shampoo. The new shampoo will soon be available at select online stores and worldwide. The product retails for $36.
About DS Healthcare Group DS Healthcare Group Inc., develops and markets skin care, personal care and hair care products. It sells through online and specialty retailers, distributors, pharmacies, doctor's offices and medical spas. Its research has led to a highly diversified and specialized portfolio of products. For more information on DS Healthcare Group's flagship brand, visit dslaboratories.com.
Follow DS Laboratories on social media: Facebook Instagram Linkedin
SOURCE DS Healthcare Group Inc.
Subscribe to our Free Newsletters!